Articles

Ultra high barrier films protect any dosage content The Pharmaceutical Industry has always mainly focused on novel drug research, formulation development,  and  subsequent  clinical  trials.  As  with  all  other  phases  it  presents  its  own  challenges. There is no use if...

Positron emission tomography (PET) is a popular nuclear imaging technique used to gain information about specific molecular biomarkers. It is often combined with other imaging technologies, such as magnetic resonance imaging (MRI) and computed tomography (CT) scanning, to incorporate...

Implantable drug-eluting devices (DEDs) have come a long way since 1938, when Finland approved a subcutaneously administered birth control device delivering levonorgestrel. Over their development history, the therapeutic performance and value of DEDs has evolved significantly, and recent innovation has...

Innovation is unarguably the essence of pharmaceutical discovery and development. Industry and academia have been working together for decades, but historically relationships did not extend far beyond the traditional exchange of funding and research. There is a risk, however,...

Antibodies are widely used in pre-clinical research to study proteins and their functions in biological pathways and diseased states. These tools, with their high specificity and sensitivity, help life science researchers to easily identify proteins of interest at various...

Preparing for Russia’s regulation requirements might seem like a mountain to climb, but it’s a necessary journey for companies that want to remain in or enter the 10th largest pharmaceutical market in the world. With the global market expected to...

Current data collection practices in clinical research are facing many challenges. There is a broad recognition that issues prevail with the current clinical research data collection processes and systems. Industry leaders, such as Janet Woodcock, of the FDA's Centre for...